5-Bromodeoxyuridine induces senescence-like phenomena in mammalian cells regardless of cell type or species

Journal of Biochemistry

Volumn 126, Issue 6, 1999, Pages 1052-1059

  Michishita, Eriko ^a   Nakabayashi, Kazuhiko ^a   Suzuki, Toshikazu ^a   Kaul, Sunil C ^b   Ogino, Hideki ^a   Fujii, Michihiko ^a   Mitsui, Youji ^b   Ayusawa, Dai ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

5 bromodeoxyuridine; Immortal; Senescence; Senescence marker; Stress

Indexed keywords

BETA GALACTOSIDASE; BROXURIDINE; COLLAGENASE; FIBRONECTIN; MESSENGER RNA; PROTEIN P16; PROTEIN P21; PROTEIN P53;

ARTICLE; CELL TYPE; EMBRYO; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; SENESCENCE;

MAMMALIA;

EID: 0033381225     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jbchem.a022549     Document Type: Article

References (38)

1. Hayflick, L. (1965) The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614-636
2. Smith, J.R. and Pereira-Smith, O.M. (1996) Replicative senescence: implications for in vivo aging and tumor suppression. Science 273, 63-67
3. Kumazaki, T., Robetorye, R.S., Robetorye, S.C., and Smith, J.R. (1991) Fibronectin expression increases during in vitro cellular senescence: correlation with increased cell area. Exp. Cell Res. 195, 13-19
4. Millis, A.J., Hoyle, M., McCue, H.M., and Martini, H. (1992) Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. Exp. Cell Res. 201, 373-379
5. Dimri, G.P. et al. (1995) A biomarker that identifies human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92, 9363-9367
6. Tahara, H., Sato, E., Noda, A., and Ide, T. (1995) Increase in expression level of p21sdi1/cip1/waf1 with increasing division age in both normal and SV40-transformed human fibroblasts. Oncogene 10, 835-840
7. CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol. 16, 859-867
8. Kulju, K.S. and Lehman, J.M. (1995) Increased p53 protein associated with aging in human diploid fibroblasts. Exp. Cell Res. 217, 336-345
9. waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases. Oncogene 16, 431-441
10. INK4A. Oncogene 15, 505-514
11. Nobori, T., Miura, K., Wu, D.J., Lois, A., Takabayashi, K., and Carson, D.A. (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753-756
12. Bond, J.A., Wyllie, F.S., and Wynford-Thomas, D. (1994) Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene 9, 1885-1889
13. Allsopp, R.C. and Harley, C.B. (1995) Evidence for a critical telomere length in senescent human fibroblasts. Exp. Cell Res. 219, 130-136
14. Gottlieb, T.M. and Oren, M. (1996) p53 in growth control and neoplasia. Biochim. Biophys. Acta 1287, 77-102
15. Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chiu, C.-P., Morin, G.B., Harley, C.B., Shay, J.W., Lichtsteiner, S., and Wright, W.E. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352
16. von Zglinicki, T., Saretzki, G., Docke, W., and Lotze, C. (1995) Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp. Cell Res. 220, 186-193
17. INK4a. Cell 88, 593-602
18. Ogryzko, V.V., Hirai, T.H., Russanova, V.R., Barbie, D.A., and Howard, B.H. (1996) Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol. Cell. Biol. 16, 5210-5218
19. Michishita, E., Nakabayashi, K., Ogino, H., Suzuki, T., Fujii, M., and Ayusawa, D. (1998) DNA topoisomerase inhibitors induce reversible senescence in normal human fibroblasts. Biophys. Biochem. Res. Commun. 253, 667-671
20. Pereria-Smith, O.M. and Smith, J.R. (1988) Genetic analysis of indefinite division in human cells: Identification of four complementation groups. Proc. Natl. Acad. Sci. USA 85, 6042-6046
21. Waldman, T., Kinzler, K.W., and Vogelstein, B. (1995) p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55, 5187-5190
22. Nakabayashi, K., Ogata, T., Fujii, M., Tahara, H., Ide, T., Wadhwa, R., Kaul, S.C., Mitsui, Y., and Ayusawa, D. (1997) Decrease in amplified telomeric sequences and induction of senescence markers by introduction of human chromosome 7 or its segments in SUSM-1. Exp. Cell Res. 235, 345-353
23. Noda, A., Ning, Y., Venable, S.F., Pereira-Smith, O.M., and Smith, J. R. (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211, 90-98
24. Fujii, M., Ogata, T., Takahashi, E., Yamada, K., Nakabayashi, K., Oishi, M., and Ayusawa, D. (1995) Expression of the human cGMP-dependent protein kinase II gene is lost upon introduction of SV40 T antigen or immortalization in human cells. FEBS Lett. 375, 263-267
25. Fujii, M., Ogata, T., Wadhwa, R., Tahara, H., Kaul, S.C., Oishi, M., and Ayusawa, D. (1995) Inhibitors of cGMP-dependent protein kinase block senescence induced by inactivation of T antigen in SV-40-transformed immortal human fibroblasts. Oncogene 11, 627-634
26. Kim, N.W., Piatyszek, M.A., Prowse, K.R., Barley, C.B., West, M.D., Ho, P.L., Coviello, G.M., Wright, W.E., Weinrich, S.L., and Shay, J. W. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015
27. Kim, N.W. and Wu, F. (1997) Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res. 25, 2595-2597
28. Wadhwa, R., Kaul, S.C., Ikawa, Y., and Sugimoto, Y. (1993) Identification of a novel member of mouse hsp 70 family, its association with cellular mortal phenotype. J. Biol. Chem. 268, 6615-6621
29. Wadhwa, R., Pereira-Smith, O.M., Reddel, R.R., Sugimoto, Y., Mitsui, Y., and Kaul, S.C. (1995) Correlation between complementation group for immortality and the cellular distribution of mortalin. Exp. Cell Res. 216, 101-105
30. Jia, L.-Q., Osada, M., Ishioka, C., Gamo, M., Ikawa, S., Suzuki, T., Shimodaira, H., Niitani, T., Kudo, T., Akiyama, M., Kimura, N., Matsuo, M., Mizusawa, H., Tanaka, N., Koyama, H., Namba, M., Kanamaru, R., and Kuroki, T. (1997) Screening the p53 status of human cell lines using a yeast functional assay. Mol. Carcinog. 19, 243-253
31. Zhu, X., Kumar, R., Mandai, M., Sharma, N., Sharma, H.W., Dhingra, U., Sokoloski, J.A., Hsiao, R., and Narayanan, R. (1996) Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc. Natl. Acad. Sci. USA 93, 6091-6095
32. Mayne, R., Elrod, B.W., Mayne, P.M., Sanderson, R.D., and Linsenmayer, T.F. (1984) Changes in the synthesis of minor cartilage collagens after growth of chick chondrocytes in 5-bromo-2′-deoxyuridine or to senescence. Exp. Cell Res. 151, 171-182
33. Anisimov, V.N. and Osipova, G.Yu. (1993) Life span reduction and carcinogenesis in the progeny of rats exposed neonatally to 5-bromo-2′-deoxyuridine. Mutat. Res. 295, 113-123
34. Morris, S.M. (1991) The genetic toxicology of 5-bromodeoxyuridine in mammalian cells. Mutat. Res. 258, 161-188
35. Bick, M.D. and Devine, E.A. (1977) Interaction of chromosomal proteins with BrdU substituted DNA as determined by chromatin-DNA competition. Nucleic Acids Res. 4, 3687-3700
36. Lin, S., Lin, D., and Riggs, A.D. (1976) Histones bind more tightly to bromodeoxyuridine-substituted DNA than to normal DNA. Nucleic Acids Res. 3, 2183-2191
37. Tsuji, H., Heartlein, M.W., and Latt, S.A. (1988) Disparate effects of 5-bromodeoxyuridine on sister-chromatid exchanges and chromosomal aberrations in Bloom syndrome fibroblasts. Mutat. Res. 198, 241-253
38. Hori, T.-A., Ayusawa, D., and Seno, T. (1984) Thymidylate stress and sister chromatid exchanges. Basic Life Sci. 29, 149-159